Metabolomics Market - includes Market Product, Application, End-user, Size, Share, Trends, Growth, Demand, Supply, Services, Segmentation, Opportunity, Market Development, capacity utilization, supply, Analysis and Forecast " to its huge collection of research reports.
The global metabolomics market is projected to reach USD 2.39 billion by 2021, at a CAGR of 14.6% during the forecast period of 2016 to 2021. The metabolomics market has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies.
In this report, the global metabolomic market is segmented by product and service, application, indication, and region. Based on product and service, this market is further segmented into two major segments—metabolomics instruments and metabolomics bioinformatics tools & services. Based on metabolomics instruments, the market is further segmented into detection tools and separation tools. The separation tools segment commanded the largest share in the global metabolomics instruments market in 2015. The large share of this segment can be attributed to the ease of separation, characterization of metabolites, and quantitation of chemical compounds achieved by separation tools such as UPLC.
Based on application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. In 2015, the biomarker discovery segment accounted for the largest share of the global metabolomics market. The personalized medicine segment is expected to register the highest CAGR during the forecast period due to collaborations between pharmaceutical companies and biotechnology firms for biomarker discovery and validation.
Metabolomics Market by type 2017-2021 by new Service spreads across 286 pages profiling 11 companies and supported with 188 tables and 42 figures available at http://www.rnrmarketresearch.com/contacts/discount?rname=67151
Global Metabolomics Market, By Application
Global Metabolomics Market, By Indication
Inborn Errors of Metabolism
Browse Here for full Report with TOC: http://www.rnrmarketresearch.com/metabolomics-biomarker-discoverymetabolite-detectionmetabolite-profiling-market-by-applications-drug-discoverytoxicology-assessment-diagnosis-indications-oncologycardiologyneurology-market-report.html
Fundamental from Table of Content
13 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, RnRMr View)*
13.2 Thermo Fisher Scientific Inc.
13.3 Agilent Technologies, Inc.
13.4 Waters Corporation
13.5 Danaher Corporation
13.6 Shimadzu Corporation
13.7 Biocrates Life Sciences AG
13.8 Bio-Rad Laboratories, Inc.
13.9 Bruker Corporation
13.10 Human Metabolome Technologies, Inc.
13.11 Leco Corporation
13.12 Metabolon, Inc.
*Details on RnRmr View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.